Open AccessCalcium Channel Blockers and Mortality in Elderly Patients With Myocardial Infarction
Author(s) -
James G. Jollis,
Ross J. Simpson,
Mridul Chowdhury,
Wayne E. Cascio,
John R. Crouse,
Mark W. Massing,
Sidney C. Smith
Publication year - 1999
Publication title -
archives of internal medicine
Language(s) - English
Resource type - Journals
eISSN - 1538-3679
pISSN - 0003-9926
DOI - 10.1001/archinte.159.19.2341
Subject(s) - medicine , myocardial infarction , cardiology , bepridil , diltiazem , atrial fibrillation , amlodipine , nifedipine , calcium channel , angina , calcium channel blocker , blood pressure , verapamil , calcium
Although calcium channel blockers are a useful therapy in relieving angina, lowering blood pressure, and slowing conduction of atrial fibrillation, growing evidence has cast doubt on their safety in patients with coronary disease.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom